Soluble Dietary Fibres in the Prevention of Type 2 Diabetes Mellitus
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01163006 |
Recruitment Status :
Completed
First Posted : July 15, 2010
Last Update Posted : January 9, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Type 2 Diabetes Mellitus Obesity | Other: Polydextrose and soluble gluco fibre | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Official Title: | Soluble Dietary Fibres as Dietetic Aid to Reduce the Risks of Type 2 Diabetes Mellitus |
Study Start Date : | March 2010 |
Actual Primary Completion Date : | March 2011 |
Actual Study Completion Date : | March 2011 |

Arm | Intervention/treatment |
---|---|
Experimental: polydextrose |
Other: Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre |
Experimental: soluble glucofibre |
Other: Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre |
Placebo Comparator: isocaloric dietary control |
Other: Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre |
Placebo Comparator: full caloric control |
Other: Polydextrose and soluble gluco fibre
Polydextrose and soluble gluco fibre |
- fat oxidation
- 24h glucose pattern

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Overweight men and women
Exclusion Criteria:
- regular smokers, athletes, diabetes mellitus

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01163006
Netherlands | |
Maastricht University | |
Maastricht, Netherlands, 6200 MD |
Responsible Party: | Maastricht University Medical Center |
ClinicalTrials.gov Identifier: | NCT01163006 |
Other Study ID Numbers: |
MEC 09-3-084 |
First Posted: | July 15, 2010 Key Record Dates |
Last Update Posted: | January 9, 2018 |
Last Verified: | July 2010 |
Diabetes Mellitus Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |